Pharma Journalist -

Alligator Bioscience announces that a license agreement has been reached with Biotheus Inc. ("Biotheus"), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the…
Read More...

Emendo Biotherapeutics announced that the company achieved the first milestone as laid out in the agreements with Takeda Pharmaceutical Company Limited (Takeda), resulting in the…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an exclusive agreement to in-license a triple reuptake inhibitor (TRI), TNX-1600 (formerly D-578), to treat posttraumatic stress disorder…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for the VX-445 (elexacaftor), tezacaftor and ivacaftor…
Read More...

Vaxxilon, a privately held company working on synthetic vaccines, has been awarded a grant of up to $1.4 million from CARB-X, with the possibility of $3.1 million more based on the…
Read More...

U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business, Bayer announced on Tuesday. The transaction is valued at 7.6…
Read More...

AstraZeneca announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint with a…
Read More...

SMi Reports: Regulation and policy to be a focus topic at the Wearable Injectors and Connected Devices conference this October The Inaugural Wearable Injectors and Connected Devices…
Read More...

The U.S. Food and Drug Administration approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another option for the…
Read More...

iBio, Inc. announced that it has entered into a Master Services Agreement with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation, to produce recombinant human…
Read More...